Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 2 min ago
Peer-reviewedCC BYJournal for ImmunoTherapy of Cancer

1027 Foundation-model-based CT detection of pneumonitis-compatible abnormalities during immune checkpoint inhibitor surveillance

4 more authors
16 affiliations
  1. 1Centre Hospitalier de Troyes, Troyes, France
  2. 2public health physician
  3. 35City of Hope, Duarte, CA, USA
  4. 410CHU Nimes, Nimes, France
  5. 51Onc.AI, Wynnewood, PA, USA
  6. 69Centre Léon Bérard, Lyon, France
  7. 710Emory University, Atlanta, GA, USA
  8. 82Onc.AI, San Carlos, CA, USA
  9. 9Baylor University Medical Center, Dallas, TX, USA
  10. 10The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA
  11. 11Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR, USA
  12. 12Onc.AI, San Carlos, CA, USA
  13. 13OhioHealth, Columbus, OH, USA
  14. 14University of Rochester Medical Center, Rochester, NY, USA
  15. 15NCI/NIH, Rochester, NY, USA
  16. 16The Center for Cancer and Blood Disorders, Fort Worth, TX, USA

Related

  1. Clinical, Radiologic, and Highest-Grade Assessment of Immune Checkpoint Inhibitor Pneumonitis in Non–Small Cell Lung Cancer
    Felipe Soto, Muhammad Ali Anees, Saadia A. Faiz +2
    Journal of immunotherapy and precision oncologyPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  2. Risk Factors for Pneumonitis in Patients with Unresectable Advanced Non-small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors
    Taisuke Isono, Akihiro Ishida, Yoko Onodera +8
    Internal MedicinePeer-reviewedCC BY-NC-NDFull textOncologyJ-STAGE
  3. Immune Checkpoint Inhibitor-Associated Pneumonitis in Patients Treated for Metastatic Renal Cell Carcinoma.
    Jack Masur, Abhishek Mullapudi, Soham Ali +10
    Current oncology (Toronto, Ont.)Peer-reviewedCC BYFull textOncologyEurope PMC
  4. Influenza A (H1N1) virus infection complicated by checkpoint inhibitor pneumonitis: A case report.
    Yifan Cheng, Huiying Zhao, Youzhong An
    MedicinePeer-reviewedCC BYFull textOncologyEurope PMC
  5. Corticosteroid-refractory checkpoint inhibitor pneumonitis in lung cancer: biological heterogeneity and mechanism-informed management
    Rong Zhang, Xiaoxue Zhang, Xiulan He +1
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0OncologyCrossref
BibTeX
@article{sanchez20261027,
  title = {{1027 Foundation-model-based CT detection of pneumonitis-compatible abnormalities during immune checkpoint inhibitor surveillance}},
  author = {Stéphane Sanchez and Jan Chrusciel and Arya Amini and JEAN-PAUL BEREGI and Chiharu Sako and Aurelie Swalduz and Ravi Parikh and Petr Jordan and Ronan J Kelly and Dwight H Owen and Brendan D Curti and Taly G Schmidt and George R Simon and Arpan A Patel and Nicholas C Love and Ray D Page},
  journal = {Journal for ImmunoTherapy of Cancer},
  year = {2026},
  month = nov,
  doi = {10.1136/jitc-2026-sitc2026.1027},
  url = {https://doi.org/10.1136/jitc-2026-sitc2026.1027},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - 1027 Foundation-model-based CT detection of pneumonitis-compatible abnormalities during immune checkpoint inhibitor surveillance
AU  - Stéphane Sanchez
AU  - Jan Chrusciel
AU  - Arya Amini
AU  - JEAN-PAUL BEREGI
AU  - Chiharu Sako
AU  - Aurelie Swalduz
AU  - Ravi Parikh
AU  - Petr Jordan
AU  - Ronan J Kelly
AU  - Dwight H Owen
AU  - Brendan D Curti
AU  - Taly G Schmidt
AU  - George R Simon
AU  - Arpan A Patel
AU  - Nicholas C Love
AU  - Ray D Page
PY  - 2026
DA  - 2026/11/07
JO  - Journal for ImmunoTherapy of Cancer
DO  - 10.1136/jitc-2026-sitc2026.1027
UR  - https://doi.org/10.1136/jitc-2026-sitc2026.1027
SN  - 2051-1426
ER  -